Summary of RCS 39
Title (Spanish): “Para ordenar al Departamento de Salud a establecer un ‘Protocolo Uniforme para la atención de Pacientes con trastornos sanguíneos y condiciones de sangrado’…"
Classification: Resolution
Bill number: RCS 39
Introduced: April 1, 2025
Current status: Referred to committee(s) in the House (appeared in House First Reading on 2025-10-23)
Purpose / Intent
The resolution directs the Puerto Rico Department of Health to develop and adopt a single, uniform clinical protocol for the care of patients with blood disorders and bleeding conditions. The intent is that all health-service facilities on the island—public and private, at primary, secondary, tertiary and supra‑tertiary levels—implement the Department‑adopted protocol to standardize diagnosis, emergency management, treatment, referral, and continuity of care for these patients.
Key provisions (as described in the title)
- Mandates the Department of Health to establish a “Protocolo Uniforme para la atención de Pacientes con trastornos sanguíneos y condiciones de sangrado.”
- Requires that all health-care facilities in Puerto Rico (public and private; primary through supra‑tertiary) adopt and follow the uniform protocol.
- Aims to ensure consistent clinical standards across levels of care for conditions such as hemophilia, von Willebrand disease, platelet function disorders, and other bleeding diatheses (and likely management of patients on anticoagulants in bleeding emergencies).
- Applies to both routine and emergency care settings (implied by scope of facilities listed).
Note: The text of the resolution beyond the title is not provided; specific contents of the protocol (clinical algorithms, timelines, training requirements, reporting, enforcement mechanisms, or funding) are not included here.
Who would be affected
- Patients with inherited or acquired bleeding disorders and related conditions.
- Health-care providers and clinical staff in emergency departments, primary care clinics, specialty clinics (hematology), surgical services, and peri‑operative care.
- Hospital and clinic administrators in both public and private sectors.
- The Department of Health (tasked with drafting, issuing, and overseeing adoption of the protocol).
- Potentially blood banks, transfusion services, and insurers depending on protocol content.
Procedural timeline and legislative actions
- 2025-04-01: Bill filed (radicado).
- 2025-04-03: Appeared in Senate First Reading; referred to committee(s).
- 2025-08-26: Committee issued first report with amendments; referred to Senate Rules & Calendar.
- 2025-10-16: Approved by the Senate in final vote with report amendments; approval text sent to the House.
- 2025-10-23: Appeared in House First Reading and referred to committee(s).
The resolution has passed the Senate (with amendments) and is under consideration in the House.
Potential impact and implementation considerations
- Standardization could improve timely diagnosis and emergency management, reduce variability in care, and lower complications from delayed or inappropriate treatment.
- Effective implementation will likely require: clinical content development with hematology experts, training programs for front‑line staff, integration into hospital protocols and electronic records, supply-chain considerations (clotting factor concentrates, blood products), and mechanisms for monitoring compliance.
- The resolution does not publicly specify funding, enforcement penalties, or the Department’s deadline to issue the protocol—items that will materially affect feasibility and timing.
Outstanding questions / uncertainties
- What is the required timeline for the Department to develop and publish the protocol?
- Will the resolution include enforcement, reporting, or accreditation-related requirements?
- Is there dedicated funding or technical support for implementation (training, supplies)?
- Will the protocol be mandatory or advisory, and how will private institutions be compelled to comply?
If you would like, I can draft a short list of recommended elements the Department should include in the protocol (clinical algorithms, emergency orders, transfusion thresholds, referral pathways, training modules, data reporting) or prepare a one‑page briefing for stakeholders.
